Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBIT Margin (2024 - 2025)

Rallybio (RLYB) has disclosed EBIT Margin for 2 consecutive years, with 2888.29% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 2765908.0% to 2888.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 3853.61% through Dec 2025, up 565834.0% year-over-year, with the annual reading at 3853.61% for FY2025, 565834.0% up from the prior year.
  • EBIT Margin hit 2888.29% in Q4 2025 for Rallybio, up from 3266.51% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 2888.29% in Q4 2025 to a low of 30547.37% in Q4 2024.